Pokémon can now treat your vision thanks to Luminopia

Pokémon has gone through many a genre makeover, but this is a new one. Teaming up with Luminopia, you can now get an assist through VR for ailments like lazy eye. It's a really cool collaboration, and you can check out the details below.

CAMBRIDGE, Mass. – September 10, 2025 – Luminopia, Inc., a digital health company pioneering a new class of treatments for neuro-visual disorders, today announced a content licensing deal with The Pokémon Company International to bring hundreds of episodes from the iconic original Pokémon animated series to pediatric amblyopia patients using Luminopia. Pokémon joins Luminopia's impressive roster of trusted media brands, including Nickelodeon, PBS Kids and Sesame Workshop. 

Through this partnership, amblyopia patients will be entertained by even more of their favorite TV characters on their journeys to improve their vision. With Ash Ketchum and his Pikachu along for the ride, kids can watch these beloved icons within a virtual reality (VR) headset, hardly realizing they're doing their treatment. 

As the leading cause of vision loss in children, amblyopia, or lazy eye, affects about one million pediatric patients nationwide. For decades, the standard of care has been eye-patching, which requires patients to cover up a patient’s “good eye” and go through their daily lives with poor vision. This can make learning, playing sports and socializing difficult, often taking an emotional toll on kids and their families. 

Luminopia reimagines the outdated approach with an FDA-cleared therapy that allows amblyopia patients to watch TV within a VR headset for one hour a day, six days a week as treatment. Luminopia works differently than eye-patching and doesn’t require a patient to cover up their good eye; instead, it encourages the brain to use both eyes together. 

Luminopia was initially cleared by the FDA for patients 4 to 7 years old in 2021. In April of this year, it was cleared for patients aged 8 to 12 years, opening the door for about 400,000 U.S. children affected by the condition in this age range.

“This partnership further expands our carefully curated content library by adding additional family-friendly shows to our platform,” said Scott Xiao, Luminopia's Co-Founder and CEO. “With our recent FDA label expansion clearance for patients aged 8 to 12 years old, our collaboration with Pokémon helps ensure even more children will have plenty of compelling, age-appropriate content to watch during treatment.” 

“At The Pokémon Company International, our mission is to bring the joy of Pokémon to as many fans as possible, including finding innovative and meaningful ways to deliver our beloved lineup of animated entertainment to children,” said Taito Okiura, vice president, marketing and media at The Pokémon Company International. “Partnering with Luminopia allows Pokémon programming to be used in an entirely new and impactful context, and we’re honored to support Luminopia’s efforts treating amblyopia.”

Parents and guardians of children with amblyopia can inquire about Luminopia with their physicians today. It’s being prescribed in top eye institutes, children's hospitals and private practices across the U.S.For more information, visit www.luminopia.com.

Stay tuned to GamingTrend for more Pokémon and Luminopia news and info!